Left ventricular mass index versus results of diastolic stress echocardiography in patients with heart failure with preserved ejection fraction

Mohammed Hassan Nashat Mohammed Bakeer; Fathi A. Maklady; Hanan M. Kamal; Ihab Magdeldin Abdel Gawwad; Islam Zakareya Mahmoud

doi:10.53730/ijhs.v8nS1.14715

Authors

Mohammed Hassan Nashat Mohammed Bakeer M.B.B.Ch, 2010, Master of cardiovascular medicine, 2015 Assistant lecturer of Cardiovascular medicine Suez Canal University
Fathi A. Maklady Professor of Cardiovascular medicine, Faculty of Medicine, Suez Canal University
Hanan M. Kamal Professor of Cardiovascular medicine, Faculty of Medicine, Suez Canal University
Ihab Magdeldin Abdel Gawwad Consultant of Cardiovascular medicine Faculty of Medicine, Suez Canal University Hospital, Suez Canal University
Islam Zakareya Mahmoud Lecturer of Cardiovascular medicine, Faculty of Medicine, Suez Canal University

Keywords:

LVMI, diastolic stress echocardiography, HFpEF

Abstract

Background: Left ventricular mass and left ventricular mass index (LVMI) is an index reflecting the thickness of the cardiac muscle, and the E/e’ ratio is a specific indicator for identifying increased left ventricular filling pressure. Limited data exist regarding the prognostic value of incorporating left ventricular mass index in heart failure with preserved ejection fraction (HFpEF). Aim: This study aimed to assess diagnostic value of LVMI at rest versus diastolic stress echo results in patients with HFpEF. Patients and methods: This study is a cross sectional descriptive study. In our study, we investigated 80 patients with unexplained exertional dyspnea with normal resting LV filling pressure at rest. Some of these patients may show elevated LV filling pressure with exercise. The current guidelines recommend to do diastolic stress echocardiography for those patients. All patients underwent complete resting echocardiography including assessment of diastolic dysfunction using the recommended 2016 guidelines and left ventricular mass index. Then we did diastolic stress echocardiography for all participants and the result of diastolic stress echocardiography was compared with the resting LVMI results.

Downloads

Download data is not yet available.

References

Hummel YM, Liu LCY, Lam CSP, Fonseca‐Munoz DF, Damman K, Rienstra M, et al. Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements. Eur J Heart Fail [Internet]. 2017;19(12):1651–60.

Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail [Internet]. 2019;21(10):1169–86.

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J [Internet]. 2019;40(40):3297–317.

Chetrit M, Cremer PC, Klein AL. Imaging of Diastolic Dysfunction in Community-Based Epidemiological Studies and Randomized Controlled Trials of HFpEF. JACC Cardiovasc Imaging [Internet]. 2020;13(1):310–26.

Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Heal [Internet]. 2020;8(3):e411–22.

Carbone S, Lavie CJ. Disparate effects of obesity on survival and hospitalizations in heart failure with preserved ejection fraction. Int J Obes [Internet]. 2020;44(7):1543–5.

Nagueh SF, Chang SM, Nabi F, Shah DJ, Estep JD. Cardiac Imaging in Patients With Heart Failure and Preserved Ejection Fraction. Circ Cardiovasc Imaging. 2017;10(9).

Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Hear J – Cardiovasc Imaging. 2016;17(11):1191–229.

Santos ABS, Roca GQ, Claggett B, Sweitzer NK, Shah SJ, Anand IS, et al. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2016 Apr;9(4):e002763–e002763.

Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute Heart Failure Syndromes. Circulation [Internet]. 2005;112(25):3958–68.

Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O’Meara E, et al. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail [Internet]. 2014/08/13. 2014 Sep;7(5):740–51.

Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, et al. Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction. Circulation [Internet]. 2011;124(23):2491–501.

Khan MS, Samman Tahhan A, Vaduganathan M, Greene SJ, Alrohaibani A, Anker SD, et al. Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail [Internet]. 2020/04/15. 2020 Jun;22(6):1032–42.

Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, et al. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction. ESC Hear Fail [Internet]. 2021/03/24. 2021 Jun;8(3):2240–7.

Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am J Cardiol [Internet]. 2013/06/28. 2013 Oct 15;112(8):1158–64.

Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol [Internet]. 2014/08/09. 2014 Oct 20;176(3):611–7.

Sambataro G, Giuffrè M, Sambataro D, Palermo A, Vignigni G, Cesareo R, et al. The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak. Diagnostics (Basel, Switzerland) [Internet]. 2020 Aug 21;10(9):619.

Blanco R, Ambrosio G, Belziti C, Lucas L, Arias A, D’Antonio A, et al. Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction. Int J Cardiol [Internet]. 2020;317:111–20.

Reddy YN V, Carter RE, Obokata M, Redfield MM, Borlaug BA. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation [Internet]. 2018 Aug 28;138(9):861–70.

Dini FL, Carluccio E, Bitto R, Ciccarelli M, Correale M, D’Agostino A, et al. Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. ESC Hear Fail [Internet]. 2022/02/05. 2022 Apr;9(2):1107–17.

van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2017;136(16).